Missed period on Mounjaro: what the evidence tells us

What the pharmacology and weight-loss evidence suggests

The Mounjaro SmPC, published on the electronic Medicines Compendium, does not list missed periods as a recognised adverse effect of tirzepatide itself. That matters, because it means the mechanism is almost certainly indirect. The SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded average body-weight reductions of around 20% at the highest dose over 72 weeks, and weight loss of that scale is well established in the clinical literature as capable of disrupting the hypothalamic-pituitary-ovarian (HPO) axis, the hormonal relay that governs ovulation and menstruation.

Put plainly: when the body loses fat relatively quickly, oestrogen production and the hormonal signals that trigger ovulation can become irregular. The menstrual cycle is surprisingly sensitive to energy balance. Some women find their periods lighten, lengthen in interval, or pause temporarily. This is physiological rather than pharmacological, the medicine is not directly targeting the reproductive system, but the metabolic shift it produces can affect it.

If you want a quick check-in with yourself before anything else, note the date your last period started and compare it against your usual cycle length. That single fact takes under a minute to recall and is the most useful piece of information to bring to any conversation with your prescriber. For broader questions about managing your dose schedule, the Mounjaro overview at nume covers the treatment pathway in plain detail.

Could this be pregnancy rather than a medication effect?

Because Mounjaro can reduce the absorption of oral contraceptives (particularly in the first four weeks of treatment and in the four weeks following any dose increase) the NHS advises women on the pill to use an additional non-oral method during those windows. This is specific to tirzepatide; the same evidence does not apply to semaglutide. The implication is straightforward: reduced contraceptive reliability plus a missed period means a pregnancy test is a reasonable and important first step, regardless of what you believe the cause to be.

Mounjaro is not recommended during pregnancy, during breastfeeding, or when trying to conceive. If a test is positive, you should stop treatment and contact your prescriber or GP the same day. This is not a situation to wait and see on. You can read the full NHS guidance on weight-management injections, which covers contraception and related considerations in detail, at NHS England's page on weight-management injections.

Women who have recently missed a dose or interrupted their schedule sometimes worry separately about how to resume safely. The guidance on what to do after a missed Mounjaro dose covers the timing questions that come up most often.

When to speak to a clinician, and what to tell them

A single delayed period during a phase of active weight loss, with no other symptoms and a negative pregnancy test, is not on its own cause for alarm. The HPO axis generally restores itself as weight stabilises. That said, persistent irregular or absent periods (particularly if accompanied by other symptoms such as significant pelvic pain, unusual discharge, or mood changes) deserve proper clinical review rather than reassurance from a website.

Your prescriber should know about menstrual changes when they conduct their clinical review before each repeat supply. At nume, a GPhC-registered prescriber reads every consultation; that review is the right moment to raise any cycle changes you have noticed, including their timing relative to starting treatment or a dose increase.

Beyond the prescription conversation, your GP is the right person to investigate whether an unrelated gynaecological or endocrine condition (such as polycystic ovary syndrome, which is itself linked to insulin resistance and overweight) is contributing. PCOS, for instance, can improve with weight loss in some people, but it can also cause irregular cycles that predate treatment. The two things can be happening simultaneously.

If your period is more than three months absent and pregnancy has been ruled out, the clinical term is secondary amenorrhoea and it warrants investigation. Side effects of any medicine can also be reported through the MHRA's Yellow Card scheme, which helps regulators track patterns in real-world use. For questions about treatment more broadly, the free consultation page is where to start a conversation with our prescribers.

People sometimes find this question comes up in the same period as other dose-related queries. If you are also thinking about what happens when a week's injection is delayed, the page on missing a week of Mounjaro addresses that specifically, and the guidance on a missed tirzepatide dose is worth reading alongside it. The underlying principle for any missed Mounjaro injection is the same: timing matters, and your prescriber or patient information leaflet is the authoritative source. If you are currently on the 5 mg dose and want to explore your pricing options, the current Mounjaro offers for the 5 mg pen are listed in one place for easy reference.